Study Group: Pain Physicians (US)(?)
Council Members in this Study Group: 511
Request a survey with this Study Group
Leading Experts in this Study Group
Daniel Wynn, MDDirector, Clinical Research
Consultants In Neurology Ltd.
Daniel Wynn, MD, FACN, FAASM, is a Director of Clinical Research at Consultants in Neurology in Chicago, Illinois. He has expertise in a wide variety of neurological illnesses and has served as a principal investigator in over 100 clinical trials in multiple sclerosis, Alzheimer's disease, stroke, chronic...
Neurologist
Medford Neurological Clinic, Inc.
Walter Carlini, MD, PhD, is a General Neurologist at Medford Neurological Clinic in Oregon. His clinical interests include stroke, epilepsy, migraine, dementia, movement disorders, and multiple sclerosis. Dr. Carlini has expertise in clinical neurophysiology and in the use of botulinum toxin injections...
Josef Parvizi, MDAttending Neurologist
Stanford University Medical Center
Josef Parvizi, MD, PhD, is an Assistant Professor of Neurological Sciences at Stanford University. Dr. Parvizi has main interest in analyzing the design and results of new clinical trials, of medications or devices, in various fields of neurology. He has clinical expertise in Alzheimer's disease, neuropathic...
Chairman of Anesthesiology and Critical Care
Westgate Medical Anesthesia Group
Sabry Ayad, MD, is a member of Westgate Medical Anesthesia Group, a private practice that provides a full range of anesthesia services for local healthcare facilities in Ohio. Through his employment at Westgate Medical Anesthesia Group, he is the Chairman of Anesthesiology and Critical Care at Fairview...
Jason Campagna, MD,PhDDirector of Clinical Quality and Analytics
Cottage Health System
Jason Campagna, MD, PhD, is an Anesthesiologist at Anesthesia Medical Group of Santa Barbara in California. He is also Director of Center for Clinical Quality and Analytics at Cottage Health System, an Adjunct Professor of neuroscience and serves as the Director of Center for Applied Neurosciences...
Director of Neurology
Wesley Headache Clinic
Stephen Landy, MD, is the Director of Neurology at Wesley Headache Clinic and Clinical Professor in Department of Neurology at University of Tennessee. Dr. Landy is certified by the National Board of Medical Examiners, the American Board of Psychiatry and Neurolgy. Also, he is certified by the National...
Ira Kornbluth, MDManaging Partner
Spine Medicine and Rehabilitation Therapies
Ira Kornbluth, MD, is the Managing Partner at Spine Medicine and Rehabilitation Therapies in Westminster, Maryland. He is board certified in Physical Medicine and Rehabilitation as well as board certified in Pain Management. He was a partner at the Center for Pain Management and DECK Pain Management...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
1. 10% of the data was rejected because the data was "fraudulent" - ie: research centers received payment, but there was not actually a patient associated with the data points. 2. No oversight was conducted of the research locations. A majority of research centers were in various 3rd world countries. ...
This should not deter the practicing physician to prescribe these agents osteoporosis will reach epidemic proportions and if we can reduce fractures by 50% the savings within the healthcare system will be enormous that's not to say that individuals albeit rare may have a propensity to develop fractures...
There are well over 70 Million general anesthetics performed in the US each year, and the majority of these utilize one of four generally used inhaled anesthetic agents (Sevoflurane, Desflurane, Isoflurane and Halothane). How these drugs act to produce "unconsciousness" is largely unknown, but as the...
1/ Genetic factors. Data indicate that genetic factors modulate the anesthetic requirement to control pain duirng and after surgery 2/ Gender sensitivity to anesthetics 3/ Anesthesia or lack of it may lead to increase postoperative pain 4/ lack of proper perioperative monitoring of pain 5/ lack...
Extavia, Novartis' brand of interferon beta 1b, has been approved for the treatment of multiple sclerosis by the European Union. With FTY72, Fingolimod, Novartis has the eye on filing NDA by the end of 2009. While essentially identical to Bayer's Betaferon interferon beta 1b,...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Owner
- President
- Director
- Partner
- Medical Director
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

